Autophagy in idiopathic pulmonary fibrosis

Pharmacology, Toxicology and Pharmaceutical Science

• Western Blot 100%
• Rapamycin 100%
• Fibrosing Alveolitis 100%
• Smooth Muscle Actin 100%
• Lung Fibrosis 100%
• Bleomycin 100%
• Fibronectin 100%
• Malignant Neoplasm 50%
• Mouse Model 50%
• Fibrosis 50%
• Confocal Microscopy 50%
• Chronic Obstructive Lung Disease 50%
• Beclin 1 50%
• Sequestosome 1 50%
• Fluorescence Microscopy 50%
• Transmission Electron Microscopy 50%
• Diseases 50%

Keyphrases

• Autophagy 100%
• Idiopathic Pulmonary Fibrosis 100%
• TGF-1 40%
• Fibroblasts 20%
• Western Blotting 20%
• Fibronectin 20%
• α-smooth muscle Actin (α-SMA) 20%
• Pulmonary Fibrosis 20%
• Mouse Model 10%
• Mammalian Target of Rapamycin (mTOR) 10%
• Lung Tissue 10%
• Dysregulation 10%
• Protein Expression 10%
• Cell Fate Decision 10%
• Human Disease 10%
• Immunofluorescence 10%
• Confocal Microscopy 10%
• Antifibrotic 10%
• Chronic Obstructive Pulmonary Disease 10%
• Rapamycin 10%
• Beclin-1 10%
• Autophagosome 10%
• Opposite Effects 10%
• Transmission Electron Microscopy 10%
• Fluorescence Microscopy 10%
• Fibrogenesis 10%
• In Vivo Experiment 10%
• Bleomycin-induced Pulmonary Fibrosis 10%
• Bleomycin 10%
• Autophagic Activity 10%
• Homeostatic Process 10%
• Autophagy Markers 10%
• Rapamycin Treatment 10%
• Human Lung Tissue 10%
• Human Lung Fibroblasts 10%
• Fibroblast Expression 10%
• TIGAR 10%
• P62 Protein 10%